Page 21 - IJB-3-2
P. 21

PERSPECTIVE

           Bioprinting of osteochondral tissues: A perspective on

           current gaps and future trends


                        1
                                          2
                                                    3,4
                                                                                           5,7
                                                                   5,6
           Pallab Datta , Aman Dhawan , Yin Yu , Dan Hayes , Hemanth Gudapati  and Ibrahim T.
           Ozbolat 5,6,7,8*
           1  Centre for Healthcare Science and Technology, Indian Institute of Engineering Science and Technology Shibpur, Howrah,
           West Bengal 711103,  India
           2  Orthopedics and Rehabilitation, Penn State University, Hershey, PA 17033, USA
           3  Department of Surgery, Harvard Medical School, Harvard University, Cambridge, MA 02138, USA
           4  The Center for Engineering in Medicine, Massachusetts General Hospital, Boston, MA 02114, USA
           5  The Huck Institutes of the Life Sciences, Penn State University, University Park, PA 16802, USA
           6  Biomedical Engineering, Penn State University, University Park, PA 16802, USA
           7  Engineering Science and Mechanics Department, Penn State University, University Park, PA 16802, USA
           8   Materials Research Institute, Penn State University, University Park, PA 16802, USA
           Abstract: Osteochondral tissue regeneration has remained a critical challenge in orthopaedic surgery, especially due to
           complications of arthritic degeneration arising out of mechanical dislocations of joints. The common gold standard of
           autografting has several limitations in presenting tissue engineering strategies to solve the unmet clinical need. However,
           due to the complexity of joint anatomy, and tissue heterogeneity at the interface, the conventional tissue engineering
           strategies have certain limitations. The advent of bioprinting has now provided new opportunities for osteochondral tissue
           engineering. Bioprinting can uniquely mimic the heterogeneous cellular composition and anisotropic extra-cellular matrix
           (ECM) organization, while allowing for targeted gene delivery to achieve heterotypic differentiation. In this perspective,
           we discuss the current advances made towards bioprinting of composite osteochondral tissues and present an account of
           challenges—in terms of tissue integration, long-term survival, and mechanical strength at the time of implantation—required
           to be addressed for effective clinical translation of bioprinted tissues. Finally, we highlight some of the future trends related
           to osteochondral bioprinting with the hope of in-clinical translation.
           Keywords: bioprinting; osteochondral injuries; zonal anisotropy; bioink; tissue engineering

           *Correspondence to: Ibrahim T. Ozbolat, The Huck Institutes of the Life Sciences, Penn State University, University Park, PA 16802, USA;
           Email: ito1@psu.edu
           Received: May 6, 2017; Accepted: June 7, 2017; Published Online: June 7, 2017

           Citation: Datta P, Dhawan A, Yu Y, et al., 2017, Bioprinting of osteochondral tissues: A perspective on current gaps and future trends.
           International Journal of Bioprinting, vol.3(2): 109–120. http://dx.doi.org/10.18063/IJB.2017.02.007.
           1. Introduction: Current Status of Osteo­           Surgical methodologies aimed at cartilage healing, such
           chondral Tissue Bioprinting                         as microfracture, grafting and autologous chondrocyte
                                                               implantation, are often complicated, costly or yield
                 amage to the articular surface in the form of   unsatisfactory results in the long-term, especially in the
                 localized cartilage erosion is usually observed   elderly population, eventually needing joint replacement
           Din relation to joint degenerative disease(s) such   to restore normal function [5–8] . To this end, regenerative
                                      [1]
           as osteoarthritis (OA) or trauma . Post-traumatic OA is
           particularly significant, since it affects a demographic   medicine that aims to repair, regenerate and improve
           that is considered too young for joint replacements. As   functionality of injured/diseased tissues holds great po-
           such, OA is one of the major chronic conditions plaguing   tential in osteochondral therapy, which involves both the
           our society, causing considerable pain and debilitation,   cartilage and bone and has generated significant interest.
           affecting an estimated 21 million people with an    However, challenges still exist in achieving this goal of
           economic burden of $89.1 billion annually in the US [2–4] .   engineering tissue structures that can closely mimic the

           Bioprinting of osteochondral tissues: A perspective on current gaps and future trends. © 2017 Pallab Datta, et al. This is an Open Access article distributed
           under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/),
           permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
                                                                                                           109
   16   17   18   19   20   21   22   23   24   25   26